Ilgen Mender

8PUBLICATIONS
34CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 11, 2025
Perioperative Management of Non-Small Cell Lung Cancer in the Era of Immunotherapy.

Ulas Kumbasar, Erkan Dikmen, Zeliha Gunnur Dikmen

|Jun 26, 2025
Novel telomere-targeting dual-pharmacophore dinucleotide prodrugs for anticancer therapy.

Ilgen Mender, Romina Girotti, Sergei Gryaznov

|Apr 18, 2023
Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma.

Ilgen Mender, Silvia Siteni, Summer Barron

|Oct 01, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas.

Shengnan Yu, Shiyou Wei, Milan Savani

|Jan 18, 2020
SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2'-Deoxyguanosine.

Ilgen Mender, Kimberly Batten, Michael Peyton

Pageof 2